Cargando…
Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial
A growing number of experimental and clinical studies have provided evidence indicating that pharmacological blockade of the renin–angiotensin system (RAS) by either angiotensin-converting enzyme inhibitors or angiotensin type 1 receptor blockers reduces the incidence of new onset type 2 diabetes in...
Autores principales: | Zhou, Ming-Sheng, Schulman, Ivonne Hernandez |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686254/ https://www.ncbi.nlm.nih.gov/pubmed/19475773 |
Ejemplares similares
-
Renovascular and renoprotective properties of telmisartan: clinical utility
por: Ladino, Marco, et al.
Publicado: (2010) -
The Advancing Field of Cell‐Based Therapy: Insights and Lessons From Clinical Trials
por: Telukuntla, Kartik S., et al.
Publicado: (2013) -
Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure
por: Premer, Courtney, et al.
Publicado: (2019) -
The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study
por: Herman, William H.
Publicado: (2015) -
Fruit Intake to Prevent and Control Hypertension and Diabetes
por: Park, Hyun Ah
Publicado: (2021)